Published in Rheum Dis Clin North Am on November 01, 2006
Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns (2008) 1.09
Absolute fracture risk reporting in clinical practice: a physician-centered survey. Osteoporos Int (2008) 0.96
Adherence to osteoporosis treatments: room for improvement. Curr Opin Rheumatol (2009) 0.93
Once-yearly zoledronic acid in hip fracture prevention. Clin Interv Aging (2009) 0.86
Factors affecting adherence to osteoporosis medications: a focus group approach examining viewpoints of patients and providers. J Geriatr Phys Ther (2011) 0.84
Osteoporosis therapies: evidence from health-care databases and observational population studies. Calcif Tissue Int (2010) 0.81
Zoledronic Acid for the treatment and prevention of primary and secondary osteoporosis. Ther Adv Musculoskelet Dis (2010) 0.78
Bone health-related factors and the use of bisphosphonates in community setting--15-year follow-up study. Osteoporos Int (2010) 0.77